294 related articles for article (PubMed ID: 35180375)
1. SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.
Chaves DG; Takahashi RHC; Campelo F; da Silva Malta MCF; de Oliveira IR; Barbosa-Stancioli EF; Ribeiro MA; Martins ML
Emerg Infect Dis; 2022 Apr; 28(4):734-742. PubMed ID: 35180375
[TBL] [Abstract][Full Text] [Related]
2. Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
Stone M; Di Germanio C; Wright DJ; Sulaeman H; Dave H; Fink RV; Notari EP; Green V; Strauss D; Kessler D; Destree M; Saa P; Williamson PC; Simmons G; Stramer SL; Opsomer J; Jones JM; Kleinman S; Busch MP;
Clin Infect Dis; 2022 Mar; 74(5):871-881. PubMed ID: 34111244
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.
Amirthalingam G; Whitaker H; Brooks T; Brown K; Hoschler K; Linley E; Borrow R; Brown C; Watkins N; Roberts DJ; Solomon D; Gower CM; de Waroux OLP; Andrews NJ; Ramsay ME
Emerg Infect Dis; 2021 Jul; 27(7):1795-1801. PubMed ID: 34152947
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study.
Prete CA; Buss LF; Whittaker C; Salomon T; Oikawa MK; Pereira RHM; Moura ICG; Delerino L; Barral-Netto M; Tavares NM; Franca RFO; Boaventura VS; Miyajima F; Mendrone-Junior A; de Almeida-Neto C; Salles NA; Ferreira SC; Fladzinski KA; de Souza LM; Schier LK; Inoue PM; Xabregas LA; Crispim MAE; Fraiji N; Araujo FLV; Carlos LMB; Pessoa V; Ribeiro MA; de Souza RE; da Silva SMN; Cavalcante AF; Valença MIB; da Silva MV; Lopes E; Filho LA; Mateos SOG; Nunes GT; Silva-Junior AL; Busch MP; Castro MC; Dye C; Ratmann O; Faria NR; Nascimento VH; Sabino EC
Elife; 2022 Sep; 11():. PubMed ID: 36135358
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic.
Schoenhals M; Rabenindrina N; Rakotondramanga JM; Dussart P; Randremanana R; Heraud JM; Andriamandimby SF; Sahondranirina PH; Vololoniaina MCA; Randriatsarafara FM; Rasolofo V; Randriamanantany ZA; Spiegel A
EBioMedicine; 2021 Jun; 68():103419. PubMed ID: 34098337
[TBL] [Abstract][Full Text] [Related]
9. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic.
Buss LF; Prete CA; Abrahim CMM; Mendrone A; Salomon T; de Almeida-Neto C; França RFO; Belotti MC; Carvalho MPSS; Costa AG; Crispim MAE; Ferreira SC; Fraiji NA; Gurzenda S; Whittaker C; Kamaura LT; Takecian PL; da Silva Peixoto P; Oikawa MK; Nishiya AS; Rocha V; Salles NA; de Souza Santos AA; da Silva MA; Custer B; Parag KV; Barral-Netto M; Kraemer MUG; Pereira RHM; Pybus OG; Busch MP; Castro MC; Dye C; Nascimento VH; Faria NR; Sabino EC
Science; 2021 Jan; 371(6526):288-292. PubMed ID: 33293339
[TBL] [Abstract][Full Text] [Related]
10. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
Uyoga S; Adetifa IMO; Karanja HK; Nyagwange J; Tuju J; Wanjiku P; Aman R; Mwangangi M; Amoth P; Kasera K; Ng'ang'a W; Rombo C; Yegon C; Kithi K; Odhiambo E; Rotich T; Orgut I; Kihara S; Otiende M; Bottomley C; Mupe ZN; Kagucia EW; Gallagher KE; Etyang A; Voller S; Gitonga JN; Mugo D; Agoti CN; Otieno E; Ndwiga L; Lambe T; Wright D; Barasa E; Tsofa B; Bejon P; Ochola-Oyier LI; Agweyu A; Scott JAG; Warimwe GM
Science; 2021 Jan; 371(6524):79-82. PubMed ID: 33177105
[TBL] [Abstract][Full Text] [Related]
12. Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.
Samore MH; Looney A; Orleans B; Greene T; Seegert N; Delgado JC; Presson A; Zhang C; Ying J; Zhang Y; Shen J; Slev P; Gaulin M; Yang MJ; Pavia AT; Alder SC
Emerg Infect Dis; 2021 Nov; 27(11):2786-2794. PubMed ID: 34469285
[TBL] [Abstract][Full Text] [Related]
13. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.
Fischer B; Knabbe C; Vollmer T
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700672
[TBL] [Abstract][Full Text] [Related]
15. Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
Erikstrup C; Hother CE; Pedersen OBV; Mølbak K; Skov RL; Holm DK; Sækmose SG; Nilsson AC; Brooks PT; Boldsen JK; Mikkelsen C; Gybel-Brask M; Sørensen E; Dinh KM; Mikkelsen S; Møller BK; Haunstrup T; Harritshøj L; Jensen BA; Hjalgrim H; Lillevang ST; Ullum H
Clin Infect Dis; 2021 Jan; 72(2):249-253. PubMed ID: 33501969
[TBL] [Abstract][Full Text] [Related]
16. Screening and Analysis of SARS-CoV-2 Antibody Among Unvaccinated Blood Donors in Chongqing, China.
Jiang Y; Huang L; Liao H; Luo C; Zhang C; Mao W
Disaster Med Public Health Prep; 2024 May; 18():e85. PubMed ID: 38699831
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
[TBL] [Abstract][Full Text] [Related]
18. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.
Nesbitt DJ; Jin DP; Hogan JW; Yang J; Chen H; Chan PA; Simon MJ; Vargas M; King E; Huard RC; Bandy U; Hillyer CD; Luchsinger LL
BMC Infect Dis; 2021 Aug; 21(1):871. PubMed ID: 34433423
[TBL] [Abstract][Full Text] [Related]
19. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
[TBL] [Abstract][Full Text] [Related]
20. Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: A cross-sectional blood donors-based study.
Moya Rios do Vale N; Roche Moreira Latini F; Prisco Arnoni C; Martins Parreira R; Batista Castelo Girão MJ; Pereira Cortez AJ; Carvalho de Souza Bonetti T
Clinics (Sao Paulo); 2022; 77():100016. PubMed ID: 35272203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
